Pre-eclampsia: pathogenesis, novel diagnostics and therapies
EA Phipps, R Thadhani, T Benzing… - Nature Reviews …, 2019 - nature.com
Pre-eclampsia is a complication of pregnancy that is associated with substantial maternal
and fetal morbidity and mortality. The disease presents with new-onset hypertension and …
and fetal morbidity and mortality. The disease presents with new-onset hypertension and …
[HTML][HTML] Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders
S Rana, SD Burke, SA Karumanchi - American journal of obstetrics and …, 2022 - Elsevier
Preeclampsia is a devastating medical complication of pregnancy that can lead to significant
maternal and fetal morbidity and mortality. It is currently believed that there is abnormal …
maternal and fetal morbidity and mortality. It is currently believed that there is abnormal …
Combining biomarkers to predict pregnancy complications and redefine preeclampsia: the angiogenic-placental syndrome
H Stepan, M Hund, T Andraczek - Hypertension, 2020 - Am Heart Assoc
Placental dysfunction underlies a spectrum of perinatal pathologies, including preeclampsia
and fetal growth restriction. Angiogenesis-related factors, including sFlt-1 (soluble fms-like …
and fetal growth restriction. Angiogenesis-related factors, including sFlt-1 (soluble fms-like …
Preeclampsia: novel mechanisms and potential therapeutic approaches
Z Armaly, JE Jadaon, A Jabbour, ZA Abassi - Frontiers in physiology, 2018 - frontiersin.org
Preeclampsia is a serious complication of pregnancy where it affects 5–8% of all
pregnancies. It increases the morbidity and mortality of both the fetus and pregnant woman …
pregnancies. It increases the morbidity and mortality of both the fetus and pregnant woman …
Meta-analysis and systematic review to assess the role of soluble FMS-like tyrosine kinase-1 and placenta growth factor ratio in prediction of preeclampsia: the …
Preeclampsia is a major cause of morbidity and mortality worldwide. Numerous candidate
biomarkers have been proposed for diagnosis and prediction of preeclampsia …
biomarkers have been proposed for diagnosis and prediction of preeclampsia …
A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre‐eclampsia: Compiled by the …
Pre-eclampsia is a multisystem disorder that typically affects 2%–5% of pregnant women
and is one of the leading causes of maternal and perinatal morbidity and mortality …
and is one of the leading causes of maternal and perinatal morbidity and mortality …
A maternal serum metabolite ratio predicts fetal growth restriction at term
Fetal growth restriction (FGR) is the major single cause of stillbirth and is also associated
with neonatal morbidity and mortality,, impaired health and educational achievement in …
with neonatal morbidity and mortality,, impaired health and educational achievement in …
Pravastatin, proton-pump inhibitors, metformin, micronutrients, and biologics: new horizons for the prevention or treatment of preeclampsia
There has been increasing research momentum to identify new therapeutic agents for the
prevention or treatment of preeclampsia, drugs that can affect the underlying disease …
prevention or treatment of preeclampsia, drugs that can affect the underlying disease …
Screening for fetal growth restriction using ultrasound and the sFLT1/PlGF ratio in nulliparous women: a prospective cohort study
F Gaccioli, U Sovio, E Cook, M Hund… - The Lancet Child & …, 2018 - thelancet.com
Background Fetal growth restriction is a major determinant of perinatal morbidity and
mortality. This condition has no gold standard definition, but a widely used proxy is delivery …
mortality. This condition has no gold standard definition, but a widely used proxy is delivery …
[HTML][HTML] Clinical interpretation and implementation of the sFlt-1/PlGF ratio in the prediction, diagnosis and management of preeclampsia
S Verlohren, SP Brennecke, A Galindo… - Pregnancy …, 2022 - Elsevier
Preeclampsia is associated with significant morbidity and mortality for mother and baby.
Although around 30% of all pregnancies are evaluated for preeclampsia, diagnosis is …
Although around 30% of all pregnancies are evaluated for preeclampsia, diagnosis is …